Colorectal Cancer | Tumor

The Impact of Clinical Trials on Metastatic Colorectal Cancer

January 22nd 2021, 5:00am

Increasing Awareness of Colorectal Cancer

January 22nd 2021, 5:00am

Timothy’s Experience With Chemotherapy for Metastatic Colorectal Cancer

January 22nd 2021, 5:00am

Typical Colorectal Cancer Diagnosis and Journey

January 22nd 2021, 5:00am

Timothy’s Experience Receiving His Colorectal Cancer Diagnosis

January 22nd 2021, 5:00am

The Role of Fight Colorectal Cancer

January 22nd 2021, 5:00am

The Nature of Colorectal Cancer

January 22nd 2021, 5:00am

Avastin-Lonsurf Combo Improves Survival in Patients with Metastatic Colorectal Cancer Ineligible for Standard Chemo

January 19th 2021, 10:00pm

In the final analysis of the phase 2 TASCO1 trial, patients within the Lonsurf and Avastin arm reached a median overall survival of 22.31 months compared with 17.67 months in the Xeloda and Avastin arm.

Counseling, Targeted Interventions Needed to Improve Health-Related Quality of Life in Young Colon Cancer Survivors

January 17th 2021, 3:00pm

The researchers concluded that the overall low health-related quality of life scores for young CRC survivors in the categories of social and functional well-being should be targeted by appropriate methods, which could include counseling and quality of life interventions.

Chronic Conditions Can Increase the Risk of Colorectal Cancer

January 17th 2021, 12:45pm

Several studies have identified an increased risk of colorectal cancer (CRC) among those suffering from a chronic condition such as Crohn’s disease, diabetes, or obesity. Interestingly, this association is particularly evident among millennials, meaning those who were in the 22-37 age group between 2014 and 2018.